Relmada Therapeutics (RLMD) Stock Price & Financial Analysis
Relmada Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Relmada Therapeutics
What is the current stock price for RLMD?
As of the latest trading session, RLMD stock trades at $6.99. The 52-week range is $0.24–$7.51, with a day range of $6.60–$7.05.
What is the P/E ratio for RLMD?
The P/E ratio (Price-to-Earnings) for RLMD is shown in the Key Statistics section. This valuation metric helps compare Relmada Therapeutics, Inc. to industry peers.
Does RLMD pay dividends?
Relmada Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for RLMD?
Based on 4 analysts, the consensus for RLMD is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of RLMD?
Relmada Therapeutics's market capitalization is $232.0M, classifying it as a micro-cap company. Relmada Therapeutics operates in the Healthcare sector within the Biotechnology industry.